Novartis AG (NVS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 27, 2026
Consensus estimate row
EPS target
$2.26
Street estimate
Revenue target
$14.57B
Street estimate
Trailing EPS (avg 4Q)
$2.17
Beat rate last 4: 50%
Latest EPS YoY
-0.4%
vs 2025-07-17
Latest revenue YoY
+0.9%
How results look so far
Trailing revenue (avg 4Q)
$13.80B
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 21, 2026
EPS beat
EPS actual / est
$2.41 / $2.17
+11.1%
Revenue actual / est
$14.41B / $14.07B
+2.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/27/2026upcoming | $2.26 | Pending | — | $14.57B | Pending | — |
| 7/21/2026 | $2.17 | $2.41 | +11.1% | $14.07B | $14.41B | +2.4% |
| 5/5/2026upcoming | $2.12 | Pending | — | — | Pending | — |
| 4/28/2026 | $2.11 | $1.99 | -5.7% | $13.44B | $13.11B | -2.4% |
| 2/4/2026 | $1.99 | $2.03 | +2.0% | $13.70B | $13.34B | -2.7% |
| 10/28/2025 | $2.26 | $2.25 | -0.4% | $13.64B | $14.36B | +5.3% |
| 7/17/2025 | $2.38 | $2.42 | +1.7% | $13.94B | $14.28B | +2.5% |
| 4/29/2025 | $2.12 | $2.28 | +7.5% | $13.90B | $13.62B | -2.0% |
| 1/31/2025 | $1.80 | $1.98 | +10.0% | $12.84B | $13.56B | +5.6% |
| 10/29/2024 | $1.94 | $2.06 | +6.2% | $12.76B | $13.17B | +3.2% |
| 7/18/2024 | $1.89 | $1.97 | +4.2% | $12.54B | $12.51B | -0.2% |
| 4/23/2024 | $1.73 | $1.80 | +4.0% | $11.44B | $11.83B | +3.4% |
| 1/31/2024 | $1.64 | $1.53 | -6.7% | $11.88B | $11.78B | -0.9% |
| 10/24/2023 | $1.70 | $1.74 | +2.4% | $12.42B | $12.09B | -2.6% |
| 7/18/2023 | $1.68 | $1.83 | +8.9% | $13.47B | $13.94B | +3.4% |
| 4/25/2023 | $1.55 | $1.71 | +10.3% | $12.72B | $13.21B | +3.9% |
| 2/1/2023 | $1.42 | $1.51 | +6.3% | $13.22B | $13.09B | -1.0% |
| 10/25/2022 | $1.57 | $1.58 | +0.6% | $12.88B | $12.84B | -0.3% |
| 7/19/2022 | $1.51 | $1.56 | +3.3% | $12.88B | $13.09B | +1.6% |
| 4/26/2022 | $1.44 | $1.46 | +1.4% | $12.62B | $12.81B | +1.5% |